Genetically Engineered Salmon Labeling Act

2017-07-11

Introduced in Senate

Genetically Engineered Salmon Labeling Act

This bill requires the market name of genetically engineered (commonly called "genetically modified" or "GMO") salmon to include "Genetically Engineered" or "GE" in front of the existing market name.

The Department of Health and Human Services must ensure that an independent scientific and technical advisory organization reports on: (1) the Food and Drug Administration (FDA) environmental assessment of AquAdvantage Salmon, and (2) each FDA environmental assessment in support of approval of a new animal drug application for a genetically engineered finfish intended for human consumption. Upon receipt of a report from the independent organization, the FDA must conduct a second environmental assessment of the fish, taking into account the report's findings. The approval of a new animal drug application for a genetically engineered fish does not take effect until the second environmental assessment of the fish is completed.

]]>

text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.